JORIFY

Glaxo Group Limited

Application Filed: 2012-07-18
Trademark Application Details
Trademark Logo JORIFY

Mark For: JORIFY™ trademark registration is intended to cover the categories of pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines. [all]

Status

2021-08-22 UTC
DEAD APPLICATION Refused Dismissed or Invalidated
This trademark application was refused, dismissed, or invalidated by the Office and this application is no longer active.


Research OneLook Acronym Finder
Serial Number85680539
Mark Literal ElementsJORIFY
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2014-03-02
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Domestic RepresentativeChristopher M. Hanes
Attorney NameChristopher M. Hanes
Attorney Docket NumberPRJ/7056097/
Law Office AssignedL40
Employee NameDUONG, ANGELA GAW

Timeline

2012-07-18Application Filed
2012-12-25Published
2012-12-25Published for Opposition
2014-03-02Location: INTENT TO USE SECTION
2016-03-21Abandon
2016-03-21Status: Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all docume
2016-03-21Status: Dead/Abandoned
2018-07-08Transaction Date

Trademark Parties (Applicants & Owners)

Party: Glaxo Group Limited
Address980 Great West Road Brentford, Middlesex UNITED KINGDOM TW89GS
Legal Entity TypeCorporation
Legal Entity StateUNITED KINGDOM

Documents

DrawingJPEG2012-07-18
TEAS Plus New ApplicationMULTI2012-07-18
Notation to FileXML2012-11-13
XSearch Search SummaryXML2012-11-13
TRAM Snapshot of App at Pub for OppostnMULTI2012-11-14
Notice of PublicationXML2012-12-05
Notification Of Notice of PublicationXML2012-12-05
OG Publication ConfirmationXML2012-12-25
Notice of AllowanceXML2013-02-19
TEAS Rev, App and/or COA of Atty/Dom.RepXML2013-03-15
Teas Change of Owner AddressXML2013-03-20
Extension of Time to File SOUXML2013-08-14
ITU Extension ApprovalXML2013-08-16
ITU Unit ActionMULTI2013-08-16
Extension of Time to File SOUMULTI2014-02-17
ITU Extension ApprovalXML2014-03-05
ITU Unit ActionMULTI2014-03-05
Extension of Time to File SOUMULTI2014-07-14
ITU Extension ApprovalXML2014-07-18
ITU Unit ActionMULTI2014-07-18
Extension of Time to File SOUMULTI2015-01-15
ITU Extension ApprovalXML2015-01-21
ITU Unit ActionMULTI2015-01-21
Change of AddressXML2015-06-23
Extension of Time to File SOUMULTI2015-06-30
ITU Extension ApprovalXML2015-07-14
ITU Unit ActionMULTI2015-07-14
Notice of AbandonmentXML2016-03-21
ITU Unit ActionMULTI2016-03-22

Attorney of Record

Christopher M. Hanes
GlaxoSmithKline
Legal Global Trademarks, Mailstop: 5.5A
Five Moore Drive
Research Triangle Park NC 27709-0183

Good, Services, and Codes

(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Filing History

DescriptionDateProceeding Number
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED2016-03-21
ABANDONMENT - NO USE STATEMENT FILED2016-03-2199999
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2015-07-14
EXTENSION 5 GRANTED2015-07-1370565
TEAS EXTENSION RECEIVED2015-06-30
EXTENSION 5 FILED2015-06-3070565
TEAS CHANGE OF CORRESPONDENCE RECEIVED2015-06-23
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2015-01-21
EXTENSION 4 GRANTED2015-01-2070565
TEAS EXTENSION RECEIVED2015-01-15
EXTENSION 4 FILED2015-01-1570565
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2014-07-18
EXTENSION 3 GRANTED2014-07-1770565
TEAS EXTENSION RECEIVED2014-07-14
EXTENSION 3 FILED2014-07-1470565
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2014-03-05
EXTENSION 2 GRANTED2014-03-0470565
CASE ASSIGNED TO INTENT TO USE PARALEGAL2014-03-0270565
TEAS EXTENSION RECEIVED2014-02-17
EXTENSION 2 FILED2014-02-1770565
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2013-08-16
TEAS EXTENSION RECEIVED2013-08-14
EXTENSION 1 GRANTED2013-08-1498765
EXTENSION 1 FILED2013-08-1498765
TEAS CHANGE OF OWNER ADDRESS RECEIVED2013-03-20
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2013-03-2088888
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2013-03-15
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2013-03-15
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2013-02-19
PUBLISHED FOR OPPOSITION2012-12-25
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2012-12-25
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2012-12-05
APPROVED FOR PUB - PRINCIPAL REGISTER2012-11-13
ASSIGNED TO EXAMINER2012-11-0883695
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2012-07-25
NEW APPLICATION ENTERED IN TRAM2012-07-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed